WntResearch has announced the appointment of Per Norlén as its new CEO. He replaces Pernilla Sandwall who has been CEO of the company since 2022. Norlén is essentially a doctor at Lund University and has worked for 20 years in various leading positions in the pharmaceutical industry and the biotechnology sector.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 SEK | +11.04% | +54.63% | +12.61% |
03/05 | WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
29/02 | WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+12.61% | 8.52M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- WNT Stock
- News WntResearch AB
- WntResearch Announces CEO Changes